During this week’s Consumer Electronics Show, FDA Principal Deputy Commissioner Amy Abernathy talks about lessons learned from the pandemic and 2021 goals.
Jennifer Fried, CEO of ExplORer Surgical, explains the stress that COVID-19 has placed on healthcare and the shift in how medical device reps are connecting with hospitals and healthcare providers.
Managing how a material can affect a device’s success starts with a strong, collaborative relationship with your materials supplier, which can help prevent a myriad of issues throughout the development of medical devices.
This year’s virtual event features experts from medical device companies, hospitals and government organizations.
As COVID-19 sweeps the globe, it’s becoming increasingly difficult for medical device leaders to navigate the arising challenges and prepare for the future.
The continued threat and spread of COVID-19 across the globe has led to seismic uncertainty for every industry.
Medical device companies are committing significant resources to the fight against Covid-19. Collaboration tools can help expedite product design while supporting evolving compliance standards.
Being prepared significantly improves the odds that an organization will successfully manage and mitigate risk, sustain trust and loyalty, and protect and preserve their brand.
Sharing more information with design partners on device function and its inherent risks can help guide better decisions during the product development process, and keep patients safer.
These three practical methods can help facilitate success.
